Clinical Trial Update: Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the efficacy and safety of oltipraz in patients with non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Oltipraz (oltipraz)

Snippet

Sponsor: PharmaKing | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED